NCT01287325View on ClinicalTrials.gov

Efficacy of DNK333 in Patients With COPD and Cough

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

April 30, 2004

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

DNK333 100 mg twice daily

DRUG

Placebo

Trial Locations (2)

Unknown

Novartis Investigative Site, Zuidlaren

Novartis Investigative Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY